dextroamphetamine transdermal (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

AdultPediatric

Attention Deficit Hyperactivity Disorder

Pending FDA approval for attention deficit hyperactivity disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Pending FDA approval for attention deficit hyperactivity disorder (ADHD) in patients aged ≥6 years

<6 years: Safety and efficacy not established

Next:

Pharmacology

Mechanism of Action

Sympathomimetic amine that promotes release of dopamine and norepinephrine from their storage sites in the presynaptic nerve terminals; may also block reuptake of catecholamines by competitive inhibition

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.